Home › NDC Lookup › RxCUI directory › RxCUI 2262293

Dexbrompheniramine maleate 2 MG Oral Tablet — RxCUI 2262293

Name: Dexbrompheniramine maleate 2 MG Oral Tablet (RxCUI 2262293)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 2262293 Semantic clinical drug · SCD ● Current RxNorm concept 1 FDA product 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI2262293

Official nameDexbrompheniramine maleate 2 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

FDA products mapped1

Package NDCs mapped2

Reported Medicaid activity (SDUD)1,037 prescriptions · 2 state & territory Medicaid programs · latest period Q4 2025

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

🕸️ Concept Web — How Dexbrompheniramine maleate 2 MG Oral Tablet Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Dexbrompheniramine maleate 2 MG Oral Tablet RxCUI 2262293 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 2

The active substance itself — no strength, form, or brand attached yet.
- Dexbrompheniramine 22696 IN
- Dexbrompheniramine maleate 48936 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Ala-Hist IR 1041509 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Dexbrompheniramine Oral Tablet 376212 SCDF
- Dexbrompheniramine maleate Oral Tablet 2647276 SCDFP
- Dexbrompheniramine Oral Product 1157768 SCDG
- Dexbrompheniramine Pill 1157769 SCDG
- Dexbrompheniramine maleate Oral Product 2661598 SCDGP
- Dexbrompheniramine maleate Pill 2659566 SCDGP
- Dexbrompheniramine Oral Tablet [Ala-Hist IR] 1041511 SBDF
- Dexbrompheniramine maleate Oral Tablet [Ala-Hist IR] 2657196 SBDFP
- +5 more in this family
Clinical & branded drugs 3

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Dexbrompheniramine maleate 2 MG 1190926 SCDC
- Dexbrompheniramine maleate 2 MG Oral Tablet [Ala-Hist IR] 2262295 SBD
- Dexbrompheniramine maleate 2 MG [Ala-Hist IR] 2262294 SBDC

Showing up to 8 concepts per family — 14 of 19 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Dexbrompheniramine maleate 2 MG SCDC · 1190926
Dexbrompheniramine Oral Tablet SCDF · 376212
Dexbrompheniramine maleate Oral Tablet SCDFP · 2647276
Dexbrompheniramine Oral Product SCDG · 1157768
Dexbrompheniramine Pill SCDG · 1157769
Dexbrompheniramine maleate Oral Product SCDGP · 2661598
Dexbrompheniramine maleate Pill SCDGP · 2659566

Brand-Name Concepts

Dexbrompheniramine maleate 2 MG Oral Tablet [Ala-Hist IR] SBD · 2262295
Dexbrompheniramine maleate 2 MG [Ala-Hist IR] SBDC · 2262294
Dexbrompheniramine Oral Tablet [Ala-Hist IR] SBDF · 1041511
Dexbrompheniramine maleate Oral Tablet [Ala-Hist IR] SBDFP · 2657196
Ala-Hist IR Oral Product SBDG · 1173474
Ala-Hist IR Pill SBDG · 1173475
Ala-Hist IR BN · 1041509

📦 FDA Products & Package NDCs

1 product · 2 package NDCs

2 package NDCs map to RxCUI 2262293 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
50991-0783-02	12 BLISTER PACK in 1 CARTON (50991-783-02) / 1 TABLET in 1...	ALA-HIST IR	Poly Pharmaceuticals, Inc.	2011-08-22
50991-0783-60	60 TABLET in 1 BOTTLE, PLASTIC (50991-783-60)	ALA-HIST IR	Poly Pharmaceuticals, Inc.	2011-08-22

Observed labelers: Poly Pharmaceuticals, Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$0.6595

Range $0.6595–$0.6595 · middle 50% $0.6595–$0.6595 · 1 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.